<collection><source>PMC</source><date>20201214</date><key>pmc.key</key><document><id>28994</id><infon key="license">NO-CC CODE</infon><passage><infon key="article-id_pmc">28994</infon><infon key="article-id_pmid">11056702</infon><infon key="article-id_publisher-id">cc-1-3-101</infon><infon key="fpage">101</infon><infon key="issue">3</infon><infon key="journal-title">Critical Care</infon><infon key="kwd">hemodialysis patient outcome prolonged mechanical ventilation renal failure renal replacement therapy respiratory failure ventilator weaning</infon><infon key="lpage">104</infon><infon key="name_0">surname:Chao;given-names:David C</infon><infon key="name_1">surname:Scheinhorn;given-names:David J</infon><infon key="name_2">surname:Stearn-Hassenpflug;given-names:Meg</infon><infon key="section_type">TITLE</infon><infon key="type">front</infon><infon key="volume">1</infon><infon key="year">1998</infon><offset>0</offset><text>Impact of renal dysfunction on weaning from prolonged mechanical ventilation</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract_title_1</infon><offset>77</offset><text>What is the backstory?</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract</infon><offset>89</offset><text>Our study examined the admission laboratory values for 1077 patients transferred to our regional weaning center (RWC) over an 8-year period. We found that the combination of mechanical ventilation and renal replacement therapy (RT) has been associated with poor outcome, high cost of care, and prolonged hospital stays in the ICU.</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract_title_1</infon><offset>677</offset><text>What are the results?</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract</infon><offset>686</offset><text>Approximately 63 patients were classified as having undergone RRT at the time of transfer, while 18 had started chronic RTG for their illness at least 2 months before being transferred to the transferring hospital. Ten patients had been initiated for RHT at our RWC; eight patients with improvement or resolution of azotemia; five patients without advanced age who did not recover from our facility due to progressive renal failure. None of the 50 patients who received ROT was able to recover. Mechanical ventilation was the standard protocol at this site.</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract</infon><offset>1447</offset><text>Out of the 63 patients who tried to wean themselves, 13% were successful, while 3% experienced failure to usher in the transition, and 84% passed away. These outcomes were significantly worse (P0.001) than those in 1014 patients with admission serum creatinine levels of  2.5 mg/dl (58% weaken, 15% failed to sow, 27% died). The study found that five patients without RRT survived regardless of progressive multisystem organ failure. No patient with severe renal dysfunction survived beyond 1 year after discharge.</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract_title_1</infon><offset>2259</offset><text>Remarks:</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract</infon><offset>2272</offset><text>The prognosis for patients who require PMV and RRT is very poor. The small number of patients with renal insufficiency not requiring RMT had a better hospital outcome and mortality, but their long-term survival was still poorer.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">title_1</infon><offset>2496</offset><text>Introduction</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>2509</offset><text>The importance of mechanical ventilation in the treatment of anaphylaxis is well established. However, there is still a need to understand the impact of mechanical ventilation on our patients' lives and the impact on their families. This study aims to investigate the impact of mechanical ventilation on weaning from prolonged mechanical ventilation on the development of anaphylaxis.

Methods:

The study involved a retrospective cohort study of 16 patients with anaphylaxis treated at three hospitals in the southern part of the city of Guizhou (Guizhou, Jiangsu Province, China). A total of 657 patients were included. The follow-up period was from the date of the last admission for anaphylaxis until the date of the last visit for anaphylaxis.

Results:

Of the 16 patients included,</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>2921</offset><text>BRH serves as a regional weaning center (RWC) for patients suffering from prolonged mechanical ventilation (PMV), and attempts are made to welch the patient away from the ICU's of nearby hospitals after 4-6 weeks of ventilator dependence. These patients typically have chronic respiratory impairment caused by an acute illness, such as an infection, ischemic heart attack, or surgical mishap.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>3362</offset><text>Previously, we observed a significant difference between the admission blood urea nitrogen (BUN) and serum creatinine of patients who were weaned but still ventilator-dependent or who persisted without treatment. In order to further clarify the impact of renal dysfunction on wetting PMV, our research involved collecting outcome data from the cohort of ventilatoripatients who had been admitted to our RWC and had not yet undergone the same process.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_1</infon><offset>3779</offset><text>Methods</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>3787</offset><text>We retrospectively reviewed the medical records of 1077 patients transferred to our RWC from 1988 to 1996. All patients with admission serum creatinine &gt; 2.5 mg/dl were included in the severe renal dysfunction cohort. Patients with admission serum creatinine &#8804; 2.5 mg/dl served as controls. We recorded demographic data, admission blood chemistries and blood gas results. The onset and etiologies of respiratory and renal failures were assessed and recorded based on the transfer records. We reviewed the patients' hospital course at the RWC and scored outcomes of weaning efforts (weaned, failed to wean, died) upon discharge. We tabulated disposition and survival data obtained from post-discharge follow-up records.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>4508</offset><text>All dialysis patients were followed by board-certified nephrologists who wrote the dialysis orders exclusively. Maintenance RRT utilized conventional intermittent hemodialysis for 2-4 h three times a week, consistent with routine practice in the United States. Bicarbonate-based dialysate and cellulose membranes were predominantly used.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>4846</offset><text>Demographic data and selected laboratory values from the two cohorts were compared and reported in terms of mean &#177; SD for normally distributed data, and median (range) for non-normal distributions. Statistical analysis included the following tests: Student's t-tests for age, serum albumin, BUN, creatinine, alveolar-arterial pressure difference [P(A-a)O2], pH; Wilcoxon Rank Sum tests for comparisons of median times spent ventilator-dependent prior to and during a patient's RWC stay and Fisher's Exact test for comparing weaning outcome and disposition results.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_1</infon><offset>5412</offset><text>Results</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>5420</offset><text>Sixty-three patients met the screening criteria. Forty patients were receiving RRT at admission to our RWC. Of the 23 patients meeting the screening criteria, but not on RRT on admission, eight (35%) had improvement or recovery of renal function while 15 experienced persistent decline to the point where RRT was indicated. Although most cases of renal failure were acute or acute on chronic, none of the 50 patients receiving RRT experienced recovery of renal function. Selected measurements on RWC admission for the study and control groups are shown in Table 1.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>5985</offset><text>Table 2 lists the etiologies of both acute and chronic causes of renal dysfunction identified from the patients' transfer records. Incomplete records and the patients' lengthy hospital courses made identification of a single specific cause of renal dysfunction difficult. Furthermore, acute insult(s) were often superimposed on underlying renal insufficiency. Typically, renal function declined during the course of sepsis or presumed sepsis, borderline or frank hypotension, the peri-operative or post-resuscitation period, and while receiving multiple medications with potential renal toxicity.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>6582</offset><text>Outcomes of weaning attempts in patients with renal dysfunction (13% weaned, 3% failed to wean, 84% died) contrasted with the 1014 control patients (58% weaned, 15% failed to wean, 27% died; P &lt; 0.001). Specific weaning outcomes for subgroups of patients are listed in Table 3. Overall outcome comparison is shown in Table 4. Only patients who stabilized or recovered renal function had outcomes comparable to the control group (4 out of 8; 50%). There was no significant difference in time taken to wean between the two groups: 36 days (22-177) for those with renal dysfunction compared to 29 days (1&#8979;226) for the control patients (P = 0.13). Ten of the 63 patients wee discharged alive, but only one was able to return home, with the remainder being discharged to extended care facilities. Post-discharge follow-up of the 10 patients showed that only four survived more than 1 month. No patient with renal dysfunction achieved 1-year survival, with 122 days being the longest post-discharge survival in that cohort. In the control group, 42% were discharged home and 37.2% of all discharges were alive at 1 year.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">title_1</infon><offset>7699</offset><text>Discussion</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>7710</offset><text>There has been increasing emphasis, partly due to a changing medical economic environment, on research into ICU outcomes and outcome prediction. Aside from the potential to influence resource utilization policy, such data have immediate benefit to clinicians, patients and families, enabling them to make more informed decisions. While outcome studies of mechanically ventilated ICU patients have proliferated, data on PMV patients in the post-ICU setting have been sparse. Patients with PMV consume a disproportionate amount of ICU resources. One cost-saving strategy is to transfer these patients, often chronically critically ill, to a long-term acute-care facility such as an RWC. We have described the PMV patient population and outcome at our RWC in two previous articles. The concurrent development of renal failure with the requirement for RRT further complicates and increases the cost of care.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>8614</offset><text>Sixty-three of 1077 ventilator-dependent patients had concurrent severe renal dysfunction on admission to our RWC; 40 of them were receiving RRT. We found that patients with renal dysfunction spent significantly more time in the ICU than controls prior to transfer to our RWC. They are also less likely to have chronic obstructive pulmonary disease as the primary reason for PMV. The extended ICU stays are most likely a reflection of higher acuity resulting in increased interventions. We found that the majority of these patients were not RRT-dependent prior to ICU entry, but had incurred various renal insults during the course of treatment, not unlike the lung injuries leading to PMV. The etiology of renal dysfunction was often multifactorial with acute insult(s) usually superimposed on chronic renal insufficiency. Although most patients developed acute renal failure necessitating RRT, none had recovery of renal function.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>9547</offset><text>We found that the combination of PMV and severe renal dysfunction on transfer to our RWC forecast a very poor outcome. This mirrors the findings in the ICU setting by Tafreshi et al, who scored outcomes for 52 ICU patients with 2 weeks of simultaneous mechanical ventilation and RRT. In that study, only three patients (6%) survived to discharge, and none were weaned. Another study by Kraman et al found that 74 of 686 respiratory failure patients developed concurrent renal failure in the ICU, with a mortality of 80%. We found an overall weaning success rate of 8% for patients with concurrent mechanical ventilation and RRT. None of the 10 patients who had RRT initiated at BRH weaned or survived to discharge, possibly reflecting progressive and irreversible organ function decline despite treatment.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>10353</offset><text>All five patients in whom RRT was withheld despite the medical indication for dialysis were in progressive multiple organ system failure (MOSF), with the decision not to initiate treatment based on a grave short-term prognosis. It is reasonable to assume that RRT would not have altered the outcome of this group. This assumption is based on the following:</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>10710</offset><text>1. mortality in renal failure is strongly dependent on comorbid conditions;</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>10786</offset><text>2. renal failure contributes to mortality independent of the fluid and metabolic derangements treated with RRT, and</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>10902</offset><text>3. despite treatment of the underlying trigger of MOSF (sepsis in these cases), and aggressive supportive therapy, the renal failure was progressive and irreversible.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>11069</offset><text>Eight of the 23 patients with admission serum creatinine levels &gt;2.5 mg/dl, but not on RRT, experienced stabilization or improvement of renal function. Four of the eight patients (50%) weaned, possibly because better renal function improved their ability to manage fluid balance, reported in our patients to improve weaning success. Despite weaning outcomes similar to that of the controls, their long-term prognosis was uniformly poor, as it was for all groups. Of the 10 patients discharged alive, the longest survival was only 22 days. Although functional status was not specifically studied, the unfavorable disposition (only one of the 10 discharged patients went home) and short survival imply a very low functional capacity and quality of life.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>11821</offset><text>It is possible that improvement in survival can be achieved with newer methods of RRT, such as the use of biocompatible membranes and continuous RRT techniques. Relative reduction in risk of death, however, is expected to be low in view of the multiple comorbid conditions in this population. Since these patients have already achieved hemodynamic stability to transfer out of the ICU setting, the indication for continuous RRT is less apparent.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>12267</offset><text>We think our results have broader clinical relevance than for the RWC alone. On the day of transfer to the RWC, the ICU team has decided the next level of care in the critical care continuum, and whether weaning efforts should continue. Caution should be exercised, however, in applying our findings to patients early in the ICU stay, in whom renal dysfunction commonly develops, but may resolve before discharge. Also, we did not capture the cohort of patients who had normal renal function on RWC admission but developed renal failure during our treatment; their prognosis remains to be studied.</text></passage><passage><infon key="section_type">CONCL</infon><infon key="type">title_1</infon><offset>12865</offset><text>Conclusion</text></passage><passage><infon key="section_type">CONCL</infon><infon key="type">paragraph</infon><offset>12876</offset><text>The prognosis for weaning success and mortality among patients with PMV and severe renal dysfunction on transfer to the RWC is poor, with poor short- and long-term survival. The duration of mechanical ventilation in the ICU before transfer was significantly longer where renal function also developed, and time to ween tended to be longer in those patients who did wet better.</text></passage><passage><infon key="fpage">323</infon><infon key="lpage">326</infon><infon key="name_0">surname:Eiseman;given-names:B</infon><infon key="name_1">surname:Beart Norton;given-names:L</infon><infon key="pub-id_pmid">841449</infon><infon key="section_type">REF</infon><infon key="source">Surg Gynecol Obstet</infon><infon key="type">ref</infon><infon key="volume">144</infon><infon key="year">1977</infon><offset>13473</offset><text>Multiple organ failure.</text></passage><passage><infon key="fpage">685</infon><infon key="lpage">693</infon><infon key="name_0">surname:Knaus;given-names:WA</infon><infon key="name_1">surname:Draper;given-names:EA</infon><infon key="name_2">surname:Wagner;given-names:DP</infon><infon key="pub-id_pmid">4073980</infon><infon key="section_type">REF</infon><infon key="source">Ann Surg</infon><infon key="type">ref</infon><infon key="volume">202</infon><infon key="year">1985</infon><offset>13497</offset><text>Prognosis in acute organ system failure.</text></passage><passage><infon key="fpage">155</infon><infon key="lpage">162</infon><infon key="name_0">surname:Rauss;given-names:A</infon><infon key="name_1">surname:Knaus;given-names:WA</infon><infon key="name_2">surname:Patois;given-names:E</infon><infon key="pub-id_pmid">2370825</infon><infon key="section_type">REF</infon><infon key="source">Med Decis Making</infon><infon key="type">ref</infon><infon key="volume">10</infon><infon key="year">1990</infon><offset>13538</offset><text> Prognosis for recovery from multiple organ system failure: the accuracy of objective estimates of chances for survival.</text></passage><passage><infon key="fpage">1505</infon><infon key="lpage">1011</infon><infon key="name_0">surname:Chertow;given-names:GM</infon><infon key="name_1">surname:Christiansen;given-names:CL</infon><infon key="name_2">surname:Cleary;given-names:PD</infon><infon key="pub-id_pmid">7605152</infon><infon key="section_type">REF</infon><infon key="source">Arch Intern Med</infon><infon key="type">ref</infon><infon key="volume">155</infon><infon key="year">1995</infon><offset>13659</offset><text> Prognostic stratification in critically ill patients with acute renal failure requiring dialysis.</text></passage><passage><infon key="fpage">204</infon><infon key="lpage">208</infon><infon key="name_0">surname:Gilbertson;given-names:AA</infon><infon key="name_1">surname:Smith;given-names:JM</infon><infon key="name_2">surname:Mostafa;given-names:SM</infon><infon key="pub-id_pmid">1744304</infon><infon key="section_type">REF</infon><infon key="source">Intensive Care Med</infon><infon key="type">ref</infon><infon key="volume">17</infon><infon key="year">1991</infon><offset>13758</offset><text>The cost of an intensive care unit: a prospective study.</text></passage><passage><infon key="fpage">134S</infon><infon key="name_0">surname:Tafreshi;given-names:M</infon><infon key="name_1">surname:Schneider;given-names:RF</infon><infon key="name_2">surname:Rosen;given-names:MJ</infon><infon key="section_type">REF</infon><infon key="source">Chest</infon><infon key="type">ref</infon><infon key="volume">108</infon><infon key="year">1995</infon><offset>13815</offset><text>Outcome of patients who require long-term mechanical ventilation and hemodialysis.</text></passage><passage><infon key="fpage">500</infon><infon key="lpage">505</infon><infon key="name_0">surname:Scheinhorn;given-names:DJ</infon><infon key="name_1">surname:Hassenpflug;given-names:M</infon><infon key="name_2">surname:Artinian;given-names:BM</infon><infon key="name_3">surname:LaBree;given-names:L</infon><infon key="name_4">surname:Catlin;given-names:JL</infon><infon key="pub-id_pmid">7842784</infon><infon key="section_type">REF</infon><infon key="source">Chest</infon><infon key="type">ref</infon><infon key="volume">107</infon><infon key="year">1995</infon><offset>13898</offset><text> Predictors of weaning after 6 weeks of mechanical ventilation. </text></passage><passage><infon key="fpage">283</infon><infon key="lpage">290</infon><infon key="name_0">surname:Cohen;given-names:IL</infon><infon key="name_1">surname:Booth;given-names:FVM</infon><infon key="pub-id_pmid">8087585</infon><infon key="section_type">REF</infon><infon key="source">New Horizons</infon><infon key="type">ref</infon><infon key="volume"> 2</infon><infon key="year">1994</infon><offset>13963</offset><text>Cost containment and mechanical ventilation in the United States.</text></passage><passage><infon key="fpage">45</infon><infon key="lpage">52</infon><infon key="name_0">surname:Daly;given-names:RJ</infon><infon key="name_1">surname:Rudy;given-names:EB</infon><infon key="name_2">surname:Thompson;given-names:KS</infon><infon key="pub-id_pmid">1988392</infon><infon key="section_type">REF</infon><infon key="source"> Heart Lung</infon><infon key="type">ref</infon><infon key="volume">20</infon><infon key="year">1991</infon><offset>14029</offset><text>Development of a special care unit for chronically critically ill patients.</text></passage><passage><infon key="fpage">534</infon><infon key="lpage">539</infon><infon key="name_0">surname:Scheinhorn;given-names:DJ</infon><infon key="name_1">surname:Artinian;given-names:BA</infon><infon key="name_2">surname:Catlin;given-names:J</infon><infon key="pub-id_pmid">8306758</infon><infon key="section_type">REF</infon><infon key="source">Chest</infon><infon key="type">ref</infon><infon key="volume">105</infon><infon key="year">1994</infon><offset>14105</offset><text> Weaning from prolonged mechanical ventilation, the experience at a regional weaning center.</text></passage><passage><infon key="fpage">1654</infon><infon key="lpage">659</infon><infon key="name_0">surname:Scheinhorn;given-names:DJ</infon><infon key="name_1">surname:Chao;given-names:DC</infon><infon key="name_2">surname:Stearn-Hassenpflug;given-names:M</infon><infon key="name_3">surname:LaBree;given-names:LD</infon><infon key="name_4">surname:Heltsley;given-names:DJ</infon><infon key="pub-id_pmid">9187189</infon><infon key="section_type">REF</infon><infon key="source">Chest</infon><infon key="type">ref</infon><infon key="volume">111</infon><infon key="year">1997</infon><offset>14198</offset><text>Post-ICU mechanical ventilation &#8980; treatment of 1123 patients at a regional weaning center.</text></passage><passage><infon key="fpage">263</infon><infon key="lpage">266</infon><infon key="name_0">surname:Kraman;given-names:S</infon><infon key="name_1">surname:Khan;given-names:F</infon><infon key="name_2">surname:Patel;given-names:S</infon><infon key="name_3">surname:Seriff;given-names:N</infon><infon key="pub-id_pmid">446058</infon><infon key="section_type">REF</infon><infon key="source">Crit Care Med</infon><infon key="type">ref</infon><infon key="volume">7</infon><infon key="year">1979</infon><offset>14291</offset><text>Renal failure in the respiratory intensive care unit.</text></passage><passage><infon key="fpage">1489</infon><infon key="lpage">1494</infon><infon key="name_0">surname:Levy;given-names:EM</infon><infon key="name_1">surname:Viscoli;given-names:CM</infon><infon key="name_2">surname:Horwitz;given-names:RI</infon><infon key="pub-id_pmid">8622223</infon><infon key="section_type">REF</infon><infon key="source">JAMA</infon><infon key="type">ref</infon><infon key="volume">275</infon><infon key="year">1996</infon><offset>14345</offset><text>The effect of acute renal failure on mortality. A cohort analysis.</text></passage><passage><infon key="fpage">1516</infon><infon key="lpage">1517</infon><infon key="name_0">surname:Turney;given-names:JH</infon><infon key="pub-id_pmid">8622229</infon><infon key="section_type">REF</infon><infon key="source">JAMA</infon><infon key="type">ref</infon><infon key="volume">275</infon><infon key="year">1996</infon><offset>14412</offset><text>Acute renal failure &#8980; a dangerous condition.</text></passage><passage><infon key="fpage">A522</infon><infon key="name_0">surname:Scheinhorn;given-names:DJ</infon><infon key="section_type">REF</infon><infon key="source">Am Rev Respir Dis</infon><infon key="type">ref</infon><infon key="volume">145</infon><infon key="year">1992</infon><offset>14459</offset><text>Increase in serum albumin and decrease in body weight correlate with weaning from prolonged mechanical ventilation.</text></passage><passage><infon key="fpage">293</infon><infon key="lpage">299</infon><infon key="name_0">surname:Neveu;given-names:H</infon><infon key="name_1">surname:Kleinknecht;given-names:D</infon><infon key="name_2">surname:Brivet;given-names:F</infon><infon key="name_3">surname:Loirat;given-names:P</infon><infon key="name_4">surname:Landais;given-names:P</infon><infon key="pub-id_pmid">8700363</infon><infon key="section_type">REF</infon><infon key="source"> Nephrol Dial Transplant</infon><infon key="type">ref</infon><infon key="volume">11</infon><infon key="year">1996</infon><offset>14575</offset><text> Prognostic factors in acute renal failure due to sepsis. Results of a prospective multicentre study. The French Study Group on Acute Renal Failure.</text></passage><passage><infon key="fpage">45</infon><infon key="lpage">54</infon><infon key="name_0">surname:Simpson;given-names:HKL</infon><infon key="name_1">surname:Allison;given-names:MEM</infon><infon key="name_2">surname:Telfer;given-names:ABM</infon><infon key="pub-id_pmid">3823507</infon><infon key="section_type">REF</infon><infon key="source">Renal Failure</infon><infon key="type">ref</infon><infon key="volume">10</infon><infon key="year">1987</infon><offset>14724</offset><text> Improving the prognosis in acute renal and respiratory failure.</text></passage><passage><infon key="section_type">FIG</infon><infon key="type">title_1</infon><offset>14789</offset><text>Figures and Tables</text></passage><passage><infon key="file">T1.xml</infon><infon key="id">T1</infon><infon key="section_type">TABLE</infon><infon key="type">table_caption</infon><offset>14808</offset><text>Comparison of demographics and selected measurements in PMV patients with and without renal dysfunction</text></passage><passage><infon key="file">T1.xml</infon><infon key="id">T1</infon><infon key="section_type">TABLE</infon><infon key="type">table</infon><infon key="xml">&lt;?xml version="1.0" encoding="UTF-8"?&gt;
&lt;table frame="hsides" rules="groups"&gt;&lt;thead&gt;&lt;tr&gt;&lt;td/&gt;&lt;td align="center"&gt;With renal dysfunction&lt;/td&gt;&lt;td align="center"&gt;without renal dysfunction&lt;/td&gt;&lt;td align="center"&gt;&lt;italic&gt;P&lt;/italic&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td/&gt;&lt;td align="center"&gt;(study group; &lt;italic&gt;n&lt;/italic&gt; = 63)&lt;/td&gt;&lt;td align="center"&gt;(control group; &lt;italic&gt;n&lt;/italic&gt; =1014)&lt;/td&gt;&lt;td/&gt;&lt;/tr&gt;&lt;/thead&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td align="left"&gt;Days of mechanical ventilation prior to transfer&lt;/td&gt;&lt;td align="center"&gt;42 (6&#8979;170)&lt;/td&gt;&lt;td align="center"&gt;33 (0&#8979;395)&lt;/td&gt;&lt;td align="center"&gt;0.04&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;Gender (% female) 53.1%&lt;/td&gt;&lt;td align="center"&gt;56.6%&lt;/td&gt;&lt;td align="center"&gt;0.61&lt;/td&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;Age&lt;/td&gt;&lt;td align="center"&gt;69.7 &#177; 11.3&lt;/td&gt;&lt;td align="center"&gt;69.1 &#177; 12.8&lt;/td&gt;&lt;td align="center"&gt;0.96&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;Serum albumin (g/dl)&lt;/td&gt;&lt;td align="center"&gt;2.72 &#177; 0.53&lt;/td&gt;&lt;td align="center"&gt;2.61 &#177; 0.60&lt;/td&gt;&lt;td align="center"&gt;0.06&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;Creatinine (mg/dl)&lt;/td&gt;&lt;td align="center"&gt;4.36 &#177; 1.69&lt;/td&gt;&lt;td align="center"&gt;0.86 &#177; 0.45&lt;/td&gt;&lt;td align="center"&gt;&amp;lt; 0.001&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;BUN (mg/dl)&lt;/td&gt;&lt;td align="center"&gt;78.6 &#177; 29.1&lt;/td&gt;&lt;td align="center"&gt;26.6 &#177; 18.2&lt;/td&gt;&lt;td align="center"&gt;&amp;lt; 0.001&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;COPD as primary reason for PMV&lt;/td&gt;&lt;td align="center"&gt;12.7%&lt;/td&gt;&lt;td align="center"&gt;24.5%&lt;/td&gt;&lt;td align="center"&gt;0.015&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;PaCO&lt;sub&gt;2&lt;/sub&gt;&lt;/td&gt;&lt;td align="center"&gt;39.4 &#177; 9.4&lt;/td&gt;&lt;td align="center"&gt;46.9 &#177; 12.2&lt;/td&gt;&lt;td align="center"&gt;&amp;lt; 0.001&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;P(A-a)O&lt;sub&gt;2&lt;/sub&gt; (mmHg)&lt;/td&gt;&lt;td align="center"&gt;107.7 &#177; 58.0&lt;/td&gt;&lt;td align="center"&gt;120.4 &#177; 74.2&lt;/td&gt;&lt;td align="center"&gt;0.26&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;pH&lt;/td&gt;&lt;td align="center"&gt;7.41 &#177; 0.07&lt;/td&gt;&lt;td align="center"&gt;7.43 &#177; 0.07&lt;/td&gt;&lt;td align="center"&gt;0.09&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;
</infon><offset>14912</offset><text>	With renal dysfunction	without renal dysfunction	P	 		(study group; n = 63)	(control group; n =1014)		 	Days of mechanical ventilation prior to transfer	42 (6&#8979;170)	33 (0&#8979;395)	0.04	 	Gender (% female) 53.1%	56.6%	0.61		 	Age	69.7 &#177; 11.3	69.1 &#177; 12.8	0.96	 	Serum albumin (g/dl)	2.72 &#177; 0.53	2.61 &#177; 0.60	0.06	 	Creatinine (mg/dl)	4.36 &#177; 1.69	0.86 &#177; 0.45	&lt; 0.001	 	BUN (mg/dl)	78.6 &#177; 29.1	26.6 &#177; 18.2	&lt; 0.001	 	COPD as primary reason for PMV	12.7%	24.5%	0.015	 	PaCO2	39.4 &#177; 9.4	46.9 &#177; 12.2	&lt; 0.001	 	P(A-a)O2 (mmHg)	107.7 &#177; 58.0	120.4 &#177; 74.2	0.26	 	pH	7.41 &#177; 0.07	7.43 &#177; 0.07	0.09	 	</text></passage><passage><infon key="file">T1.xml</infon><infon key="id">T1</infon><infon key="section_type">TABLE</infon><infon key="type">table_foot</infon><offset>15511</offset><text>BUN = blood urea nitrogen; COPD = chronic obstructive pulmonary disease; PMV = prolonged mechanical ventilation; PaCO2 = partial pressure of arterial carbon dioxide; P(A-a)O2 = alveolar-arterial pressure difference.</text></passage><passage><infon key="file">T2.xml</infon><infon key="id">T2</infon><infon key="section_type">TABLE</infon><infon key="type">table_caption</infon><offset>15727</offset><text>Determinants of dysfunction in PMV patients: underlying factors and acute insults</text></passage><passage><infon key="file">T2.xml</infon><infon key="id">T2</infon><infon key="section_type">TABLE</infon><infon key="type">table</infon><infon key="xml">&lt;?xml version="1.0" encoding="UTF-8"?&gt;
&lt;table frame="hsides" rules="groups"&gt;&lt;thead&gt;&lt;tr&gt;&lt;td align="left"&gt;Underlying renal insufficiency&lt;/td&gt;&lt;td align="left"&gt;Acute insults&lt;/td&gt;&lt;/tr&gt;&lt;/thead&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td align="left"&gt;Age&lt;/td&gt;&lt;td align="left"&gt;Post-surgical (mostly post-CABG)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;Diabetes&lt;/td&gt;&lt;td align="left"&gt;Cardiac arrest&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;Hypertension&lt;/td&gt;&lt;td align="left"&gt;Sepsis/MOSF&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;Congestive heart failure&lt;/td&gt;&lt;td align="left"&gt;Hypotension&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;Renal artery stenosis&lt;/td&gt;&lt;td align="left"&gt;Antibiotic toxicity&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;Renal allograft dysfunction&lt;/td&gt;&lt;td align="left"&gt;Renal allograft rejection&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;Glomerulonephritis&lt;/td&gt;&lt;td align="left"&gt;Cholesterol emboli&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;
</infon><offset>15809</offset><text>Underlying renal insufficiency	Acute insults	 	Age	Post-surgical (mostly post-CABG)	 	Diabetes	Cardiac arrest	 	Hypertension	Sepsis/MOSF	 	Congestive heart failure	Hypotension	 	Renal artery stenosis	Antibiotic toxicity	 	Renal allograft dysfunction	Renal allograft rejection	 	Glomerulonephritis	Cholesterol emboli	 	</text></passage><passage><infon key="file">T2.xml</infon><infon key="id">T2</infon><infon key="section_type">TABLE</infon><infon key="type">table_foot</infon><offset>16128</offset><text>MOSF = multiple organ system failure; PMV=prolonged mechanical ventilation; CABG=coronary artery bypass graft.</text></passage><passage><infon key="file">T3.xml</infon><infon key="id">T3</infon><infon key="section_type">TABLE</infon><infon key="type">table_caption</infon><offset>16239</offset><text>Outcomes of weaning attempts in patients with renal dysfunction, by sub-group</text></passage><passage><infon key="file">T3.xml</infon><infon key="id">T3</infon><infon key="section_type">TABLE</infon><infon key="type">table</infon><infon key="xml">&lt;?xml version="1.0" encoding="UTF-8"?&gt;
&lt;table frame="hsides" rules="groups"&gt;&lt;thead&gt;&lt;tr&gt;&lt;td align="left"&gt;Sub-group&lt;/td&gt;&lt;td align="center"&gt;&lt;italic&gt;n&lt;/italic&gt;&lt;/td&gt;&lt;td align="center"&gt;Weaned&lt;/td&gt;&lt;td align="center"&gt;Failed to wean&lt;/td&gt;&lt;td align="center"&gt;Died&lt;/td&gt;&lt;/tr&gt;&lt;/thead&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td align="left"&gt;RRT initiated &amp;gt; 2 months prior to initial hospitalization&lt;/td&gt;&lt;td align="center"&gt;18&lt;/td&gt;&lt;td align="center"&gt;1&lt;/td&gt;&lt;td align="center"&gt;1&lt;/td&gt;&lt;td align="center"&gt;16&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;RRT initiated at transferring facility and continued at RWC&lt;/td&gt;&lt;td align="center"&gt;22&lt;/td&gt;&lt;td align="center"&gt;3&lt;/td&gt;&lt;td align="center"&gt;1&lt;/td&gt;&lt;td align="center"&gt;18&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;RRT initiated at RWC&lt;/td&gt;&lt;td align="center"&gt;10&lt;/td&gt;&lt;td align="center"&gt;0&lt;/td&gt;&lt;td align="center"&gt;0&lt;/td&gt;&lt;td align="center"&gt;10&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;RRT indicated but withheld&lt;/td&gt;&lt;td align="center"&gt;5&lt;/td&gt;&lt;td align="center"&gt;0&lt;/td&gt;&lt;td align="center"&gt;0&lt;/td&gt;&lt;td align="center"&gt;5&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;RRT not indicated&lt;/td&gt;&lt;td align="center"&gt;8&lt;/td&gt;&lt;td align="center"&gt;4&lt;/td&gt;&lt;td align="center"&gt;0&lt;/td&gt;&lt;td align="center"&gt;4&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;Total&lt;/td&gt;&lt;td align="center"&gt;63&lt;/td&gt;&lt;td align="center"&gt;8&lt;/td&gt;&lt;td align="center"&gt;2&lt;/td&gt;&lt;td align="center"&gt;53&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;
</infon><offset>16317</offset><text>Sub-group	n	Weaned	Failed to wean	Died	 	RRT initiated &gt; 2 months prior to initial hospitalization	18	1	1	16	 	RRT initiated at transferring facility and continued at RWC	22	3	1	18	 	RRT initiated at RWC	10	0	0	10	 	RRT indicated but withheld	5	0	0	5	 	RRT not indicated	8	4	0	4	 	Total	63	8	2	53	 	</text></passage><passage><infon key="file">T3.xml</infon><infon key="id">T3</infon><infon key="section_type">TABLE</infon><infon key="type">table_foot</infon><offset>16617</offset><text>RRT = renal replacement theraphy; RWC = regional weaning center.</text></passage><passage><infon key="file">T4.xml</infon><infon key="id">T4</infon><infon key="section_type">TABLE</infon><infon key="type">table_caption</infon><offset>16682</offset><text>Comparison of outcome and 1 year survival in PMV patients with and without renal dysfunction</text></passage><passage><infon key="file">T4.xml</infon><infon key="id">T4</infon><infon key="section_type">TABLE</infon><infon key="type">table</infon><infon key="xml">&lt;?xml version="1.0" encoding="UTF-8"?&gt;
&lt;table frame="hsides" rules="groups"&gt;&lt;thead&gt;&lt;tr&gt;&lt;td/&gt;&lt;td align="center"&gt;Renal dysfunction&lt;/td&gt;&lt;td align="center"&gt;Control group&lt;/td&gt;&lt;td align="center"&gt;&lt;italic&gt;P&lt;/italic&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td/&gt;&lt;td align="center"&gt;group (&lt;italic&gt;n&lt;/italic&gt; = 63)&lt;/td&gt;&lt;td align="center"&gt;(&lt;italic&gt;n&lt;/italic&gt; = 1014)&lt;/td&gt;&lt;td/&gt;&lt;/tr&gt;&lt;/thead&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td align="left"&gt;Weaning outcome:&lt;/td&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;&#8195;Weaned&lt;/td&gt;&lt;td align="center"&gt;13%&lt;/td&gt;&lt;td align="center"&gt;58%&lt;/td&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;&#8195;Failed to wean&lt;/td&gt;&lt;td align="center"&gt;3%&lt;/td&gt;&lt;td align="center"&gt;15%&lt;/td&gt;&lt;td align="center"&gt;&amp;lt; 0.001&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;&#8195;Died&lt;/td&gt;&lt;td align="center"&gt;84%&lt;/td&gt;&lt;td align="center"&gt;27%&lt;/td&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;Time to wean at BRH (days)&lt;/td&gt;&lt;td align="center"&gt;36 (22&#8979;177)&lt;/td&gt;&lt;td align="center"&gt;29 (1&#8979;226)&lt;/td&gt;&lt;td align="center"&gt;0.13&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;Alive 1 year post discharge&lt;/td&gt;&lt;td align="center"&gt;0%&lt;/td&gt;&lt;td align="center"&gt;37.2%&lt;/td&gt;&lt;td align="center"&gt;0.029&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;
</infon><offset>16775</offset><text>	Renal dysfunction	Control group	P	 		group (n = 63)	(n = 1014)		 	Weaning outcome:				 	&#8195;Weaned	13%	58%		 	&#8195;Failed to wean	3%	15%	&lt; 0.001	 	&#8195;Died	84%	27%		 	Time to wean at BRH (days)	36 (22&#8979;177)	29 (1&#8979;226)	0.13	 	Alive 1 year post discharge	0%	37.2%	0.029	 	</text></passage><passage><infon key="file">T4.xml</infon><infon key="id">T4</infon><infon key="section_type">TABLE</infon><infon key="type">table_foot</infon><offset>17046</offset><text>PMV = prolonged mechanical ventilation; BRH = Barlow Respiratory Hospital.</text></passage></document></collection>